Europe PMC Monthly counts of biology and medicine research naming AI methods, since 2015: bioRxiv and medRxiv preprints, PubMed papers, four laboratory control methods, and AI's share of each corpus.
All three collections grew a lot since 2015, so the counts rise for that reason too — read the share charts instead.
AI share of biology preprints derived 7.0% −8.9% yr as of Sep 2026
0 2 4 6 8 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra Preprints that name an AI method ÷ every bioRxiv preprint that month. Corpus size The size of each collection. Every share chart divides by one of these three counts.
All bioRxiv preprints 5.0k +5.3% yr as of Sep 2026
0 1.0k 2.0k 3.0k 4.0k 5.0k 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra
All medRxiv preprints 1.5k +7.1% yr as of Sep 2026
0 500 1.0k 1.5k 2.0k 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra
All PubMed records 130k −4.9% yr as of Sep 2026
0 20.0k 40.0k 60.0k 80.0k 100k 120k 140k 160k 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra AI methods in biology preprints These charts count abstracts that name the method. One preprint can name several methods, so never add the charts together.
Any AI method named 354 −4.1% yr as of Sep 2026
0 100 200 300 400 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra Abstracts that name any of eleven AI terms, from “machine learning” to “AlphaFold”. Each preprint counts once.
"machine learning" 135 −17.7% yr as of Sep 2026
0 20 40 60 80 100 120 140 160 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra
"deep learning" 86 −27.7% yr as of Sep 2026
0 20 40 60 80 100 120 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra
"neural network" 36 −30.8% yr as of Sep 2026
0 10 20 30 40 50 60 70 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra
Large language models 37 +117.6% yr as of Sep 2026
0 10 20 30 40 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra
"transformer" 33 +26.9% yr as of Sep 2026
0 10 20 30 40 50 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra
"foundation model" 23 +187.5% yr as of Sep 2026
0 5 10 15 20 25 30 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra
Generative models 10 −16.7% yr as of Sep 2026
0 2 4 6 8 10 12 14 16 18 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra Structure, design and screening What researchers use AI for. One preprint can name several of these methods, so never add the charts together.
AlphaFold 35 +40.0% yr as of Sep 2026
0 10 20 30 40 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra
Protein language models 21 +31.3% yr as of Sep 2026
0 5 10 15 20 25 30 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra
Molecular docking 23 +35.3% yr as of Sep 2026
0 5 10 15 20 25 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra
Protein design 15 −25.0% yr as of Sep 2026
0 5 10 15 20 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra
Virtual screening 10 +66.7% yr as of Sep 2026
0 2 4 6 8 10 12 14 16 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra Control methods Controls: laboratory methods with no AI in them. They show how much of the growth is only bioRxiv getting bigger.
RNA-seq 97 −3.0% yr as of Sep 2026
0 20 40 60 80 100 120 140 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra
Mass spectrometry 116 +8.4% yr as of Sep 2026
0 20 40 60 80 100 120 140 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra
CRISPR 129 +20.6% yr as of Sep 2026
0 20 40 60 80 100 120 140 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra
Cryo-EM 55 +25.0% yr as of Sep 2026
0 10 20 30 40 50 60 70 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra Clinical preprints (medRxiv) medRxiv opened in June 2019, so these charts start there.
Any AI method named 170 −2.3% yr as of Sep 2026
0 50 100 150 200 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra Abstracts that name any of eleven AI terms, from “machine learning” to “AlphaFold”. Each preprint counts once.
"deep learning" 28 −15.2% yr as of Sep 2026
0 10 20 30 40 50 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra
Large language models 46 +84.0% yr as of Sep 2026
0 10 20 30 40 50 60 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra Published biomedical literature (PubMed)
Any AI method named 6.8k +4.9% yr as of Sep 2026
0 2.0k 4.0k 6.0k 8.0k 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra Abstracts that name any of eleven AI terms, from “machine learning” to “AlphaFold”. Each paper counts once.
"artificial intelligence" 2.5k +25.4% yr as of Sep 2026
0 500 1.0k 1.5k 2.0k 2.5k 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra
"deep learning" 1.4k −13.5% yr as of Sep 2026
0 500 1.0k 1.5k 2.0k 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra
Large language models 416 +59.4% yr as of Sep 2026
0 100 200 300 400 500 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra
ChatGPT 224 −15.5% yr as of Sep 2026
0 50 100 150 200 250 300 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra
CRISPR 701 +0.1% yr as of Sep 2026
0 200 400 600 800 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra A control: CRISPR is not an AI method. It shows how much of the growth is only PubMed getting bigger. Share These shares count abstracts that name a method. A paper that uses AI without naming it does not count.
CRISPR share of biology preprints derived 2.6% +14.7% yr as of Sep 2026
0 0.5 1 1.5 2 2.5 3 3.5 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra A control. Preprints that name CRISPR ÷ every bioRxiv preprint that month.
AI share of clinical preprints derived 11.0% −8.7% yr as of Sep 2026
0 2 4 6 8 10 12 14 16 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra Preprints that name an AI method ÷ every medRxiv preprint that month.
AI share of published biomedicine derived 5.2% +10.1% yr as of Sep 2026
0 1 2 3 4 5 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Copilot GA Claude 3 Gemini 2.5 Pro GPT-6 Astra Papers that name an AI method ÷ every PubMed record that month. read this against ← back to all sources